The article presents a panel discussion at the North Carolina Biotechnology Center in Research Triangle Park about contract-research organizations (CROs) and the future of the industry. CROs reportedly partner with biopharmaceutical sector to provide services throughout a product's life cycle. CROs mitigate risk in advising how to establish protocols and how to approach the U.S. Food and Drug Administration (FDA). CROs are predicted to grow worldwide and become more knowledge-based.
Processing Request
No Comments.